# Contact Dermatitis

Evaluate dermatitis through a structured exposure history, distinguish irritant from allergic mechanisms, use patch testing when contact allergy is plausible, and make relevance—not test positivity alone—the basis for avoidance and occupational interventions.

**Clinical question:** How should clinicians distinguish irritant from allergic contact dermatitis and use patch testing to direct management?

Updated: 2026-09-15T23:16:43.225289+00:00

## What matters in practice
- Irritant contact dermatitis is a nonimmunologic consequence of direct barrier injury and is the predominant form of contact dermatitis; allergic and irritant mechanisms may coexist in the same patient. [1][3][8]
- Order patch testing when allergic contact dermatitis is suspected or must be excluded, including in children and at any dermatitis site; a positive result requires exposure-based relevance assessment before it directs avoidance. [6]
- Patch testing cannot establish irritant contact dermatitis, and biopsy cannot reliably distinguish allergic from irritant contact dermatitis or from other eczematous disorders. [7]
- In occupational hand dermatitis, specifically identify wet work, cleansing agents, solvents, dusts, gloves, and workplace products; interdigital dermatitis can be an early sentinel finding of wet-work irritant dermatitis. [17][19]
- Avoidance of identified irritants and clinically relevant allergens is the central disease-modifying intervention; topical corticosteroids and topical calcineurin inhibitors are treatment options for active dermatitis. [1][3]

## Branch the evaluation by exposure pattern and mechanism

Use morphology and distribution to target an exposure investigation rather than to assign mechanism alone.

Begin with an exposure inventory tied to the eruption map: occupation and tasks; frequency and duration of water exposure; soaps, alcohol-based sanitizers, disinfectants, solvents, cleaning agents, dusts, gloves, cosmetics, jewelry, topical medications, and hobbies. Frequent or prolonged water exposure, solvents, cleaning agents, and dust are characteristic irritant triggers; healthcare, food-service, manufacturing, cosmetic, and metalworking work increases occupational risk. [1][17][19]

Favor irritant contact dermatitis when dermatitis follows cumulative or direct exposure to barrier-damaging agents, particularly on the hands in wet-work settings. Interdigital dermatitis is an early occupational hand irritant dermatitis signal and should trigger review of handwashing, sanitizer, glove, and cleaning practices before disease becomes chronic. [19]

Favor allergic contact dermatitis when the history suggests sensitization to a specific external product or material and when an exposure-linked distribution persists despite basic irritant reduction. Because clinical appearance, histology, and even management often overlap in chronic allergic and irritant dermatitis, do not infer mechanism from chronic eczematous morphology alone. [3][8][17]
- Document the temporal relation to work shifts, product introduction, new gloves or personal-care products, and improvement away from the suspected exposure. [1][17]
- Obtain product labels, safety data sheets, and representative workplace or personal products for later allergen correlation and, when appropriate, testing. Patch testing with patients' own materials can clarify relevance to standard-allergen reactions. [6]
- Consider mixed disease rather than choosing a single label when wet work or chemical exposure coexists with plausible allergy; occupational contact dermatitis may be allergic or irritant. [3][19]

*Clinical distinctions that determine whether patch testing can change management. [3][6][7][17][19]*

| Decision feature | Irritant contact dermatitis | Allergic contact dermatitis | Next action |
| --- | --- | --- | --- |
| Mechanistic clue | Direct, nonspecific barrier injury from external agents or environmental factors. [8][19] | Contact sensitization to an allergen with exposure-related dermatitis. [6][17] | Assess every suspected exposure; coexistence is possible. [3][8] |
| High-yield exposure history | Frequent/prolonged water contact, soaps, sanitizers, solvents, cleaning agents, dust, and wet work. [17][19] | Specific consumer, workplace, cosmetic, metal, rubber, medication, or other material exposure requiring allergen correlation. [1][6] | Obtain labels and workplace materials; map exposure to affected skin. [6] |
| Diagnostic test | No standard diagnostic test establishes irritant contact dermatitis. [7] | Patch testing identifies contact sensitization when properly performed and interpreted. [6][7] | Order patch testing when allergy is suspected or requires exclusion. [6] |
| Biopsy | Cannot distinguish irritant from allergic contact dermatitis. [7] | Cannot distinguish allergic from irritant contact dermatitis or other eczematous eruptions. [7] | Do not use histology to assign allergic versus irritant mechanism. [7] |

## Use patch testing to identify relevant allergy, not merely sensitization

Patch testing answers whether contact sensitization is present; clinical relevance establishes whether it explains the eruption.

Perform diagnostic patch testing in patients with dermatitis when contact allergy is suspected or needs exclusion, regardless of age or anatomic site. Use a baseline series and add exposures suggested by the clinical history; testing the patient's own products or materials can help determine whether a standard-series reaction is clinically relevant. [6]

A standard procedure applies allergens under occlusion, removes patches at 48 hours, and requires a delayed reading after removal; delayed reactions are integral to interpretation. In the cited device-reaction case, readings at removal and 72 hours changed the interpretation from a questionable to a positive nickel sulfate reaction, illustrating why delayed assessment matters. [2][7]

Interpret each positive reaction against actual exposure. A positive reaction to a product containing the sensitizer, when the patient is exposed to that product, usually supports current relevance. Distinguish current relevance from past relevance, such as a prior nickel-associated earring dermatitis in a patient who remains nickel patch-test positive. [6]
- Do not equate a positive patch test with causation: relevance can be absent, and published vulvar dermatitis data show a wide range of relevance among positive reactions. [5][6]
- Proceed with patch testing in patients receiving immunosuppression when allergy is clinically important, but interpret a negative result cautiously because false-negative reactions may occur. [6]
- Leave testing of unknown chemicals and potentially irritating materials to clinicians experienced in patch testing because irritant reactions and interpretation errors can misclassify exposure risk. [7]

### What a patch-test result changes

For a relevant positive result, give allergen-specific avoidance instructions, identify the exposure source through ingredient and workplace-material review, and replace or eliminate the implicated product. For a negative or irrelevant result with a strong wet-work or chemical pattern, prioritize an irritant-reduction plan rather than pursuing allergy-directed elimination. [1][6][17][19]

*Patch-test interpretation workflow. [2][6][7]*

| Result or situation | Interpretation | Clinical action |
| --- | --- | --- |
| Positive reaction plus ongoing exposure to a product containing the allergen | Usually indicates clinically relevant contact allergy when product exposure is established. [6] | Eliminate or substitute the implicated product and provide exposure-specific avoidance counseling. [1][6] |
| Positive reaction without plausible present exposure | May reflect past relevance or sensitization without current causation. [6] | Do not attribute the active eruption to the allergen without exposure correlation. [6] |
| Negative test during immunosuppression | False-negative reactions may occur. [6] | Reassess the exposure history and interpret the negative result cautiously. [6] |
| Testing with unknown or irritant material | May yield difficult-to-interpret irritant reactions. [7] | Use experienced patch-test personnel and cautious test selection. [7] |

## Target hand, occupational, and genital exposures differently

Anatomic site narrows the product and task inventory; it does not remove the need for relevance assessment.

For hand disease, ask specifically about wet work, handwashing frequency, alcohol-based sanitizer use, glove use, food handling, cleaning chemicals, and occupational dust or solvents. Healthcare workers, food-service workers, hairdressers, beauticians, cooks, florists, metalworkers, and manufacturing workers are repeatedly identified as high-risk groups for occupational contact dermatitis. [1][19]

Treat occupational onset as an exposure-control problem as well as a skin diagnosis. About half of observed occupational contact dermatitis cases develop within the first 2 years of employment; early education on hazardous skin exposures, appropriate personal protective equipment, and early recognition of dermatitis is therefore a practical prevention opportunity. [19]

For vulvar dermatitis, first remove putative irritants and investigate potential allergens through a detailed product history; patch testing is widely used as part of the diagnostic assessment, but positive reactions must still be judged for relevance to the patient's exposures. [5]
- Ask about glove composition and additives, because rubber compounds are among screening-series categories and occupational glove exposure can be clinically important. [7][16]
- For cosmetics or topical products, compare the product ingredient list with positive standard-series allergens; concordant testing and exposure increase the likelihood of relevance. [6]
- For suspected metal allergy, recognize nickel as a common contact allergen, but do not use a positive result alone to predict reaction to implanted nickel-containing cardiac closure devices; reported device-related allergic events are rare and preimplantation screening remains controversial. [2]

*Exposure-directed history for common contact-dermatitis presentations. [1][5][6][7][19]*

| Presentation | History to obtain | Diagnostic implication | Immediate exposure step |
| --- | --- | --- | --- |
| Hand dermatitis in wet-work occupation | Water, soaps, sanitizers, detergents, cleaning agents, glove practices, solvents, and work timing. [17][19] | Supports irritant dermatitis; assess for superimposed allergy when disease persists or exposure pattern is insufficient. [3][6] | Reduce identified irritant contact and review protective practices. [1][19] |
| Dermatitis after cosmetics or topical products | Product names, ingredient labels, application sites, onset after use, and prior reactions. [6] | Patch testing with baseline allergens and the patient's own materials may establish relevant allergy. [6] | Stop the suspected product while testing and relevance assessment proceed. [1][6] |
| Vulvar dermatitis | All products and irritants contacting vulvar skin, including topical preparations and hygiene products. [5] | Patch testing is an adjunct to history and examination when allergic contact dermatitis is considered. [5] | Avoid putative irritants and any identified relevant allergen. [5] |

## Pair exposure elimination with anti-inflammatory control

Treatment fails when inflammation is suppressed but the causative exposure continues.

Make avoidance the core intervention for both allergic and irritant disease: eliminate the relevant allergen when patch testing and exposure history establish causation, and reduce cumulative contact with water, cleansers, solvents, and other identified irritants in irritant disease. Patient education and specific avoidance strategies are central management elements. [1][3][5][19]

Treat active inflammation with topical corticosteroids or topical calcineurin inhibitors; the provided evidence identifies these as treatment options but does not establish regimen-specific dosing. For severe or recalcitrant contact dermatitis, phototherapy and systemic therapies have been used, with escalation selected after confirming that ongoing exposure has been addressed. [1][3]

Refer for dermatology-directed patch testing when a relevant allergen is plausible, dermatitis is persistent or occupationally consequential, the suspected material is complex or unknown, or interpretation of weak, delayed, or potentially irritant reactions will determine work or product restrictions. Patch-test expertise is particularly important because a result is clinically useful only after relevance assessment. [6][7][9]
- Reassess after avoidance by confirming whether the patient actually eliminated the implicated product, ingredient, or work exposure rather than assuming therapeutic failure. [1][6]
- In occupational disease, document implicated tasks and materials and use the exposure inventory to guide workplace modification and personal protective equipment counseling. [17][19]
- Escalate persistent disease despite verified avoidance to reconsider mixed allergic-irritant disease, ongoing unrecognized exposure, or an alternative eczematous diagnosis; biopsy will not resolve the allergic-versus-irritant distinction. [3][7][8]

*Management decisions after the initial evaluation. [1][3][5][6][7][19]*

| Clinical scenario | Priority intervention | Role of testing or escalation |
| --- | --- | --- |
| Probable irritant dermatitis with clear wet-work or chemical exposure | Reduce or eliminate identified irritants and optimize exposure protection; use topical anti-inflammatory therapy for active disease. [1][19] | Patch testing is not a test for irritant dermatitis but is appropriate if allergic contact dermatitis remains plausible. [6][7] |
| Patch-test positive with established current exposure | Eliminate the allergen-containing product or material and treat active dermatitis with topical therapy. [1][6] | Confirm clinical improvement after avoidance to support causal relevance. [6] |
| Persistent dermatitis with uncertain trigger | Repeat a structured exposure inventory and assess for mixed disease. [3][17] | Refer for expanded and patient-product patch testing; avoid relying on biopsy to distinguish allergic from irritant disease. [6][7] |
| Severe or recalcitrant disease after exposure control | Consider dermatology-directed phototherapy or systemic treatment in addition to topical therapy. [1][3] | Verify that relevant exposures have been removed before labeling disease treatment-refractory. [1][6] |

## References
1. Contact dermatitis | The BMJ — www.bmj.com — https://www.bmj.com/content/bmj/353/bmj.i3299.full.pdf
2. Systemic Allergic Contact Dermatitis Due to a GORE CARDIOFORM Septal Occluder Device: A Case Report and Literature Review — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jaccas.2020.05.091
3. Contact dermatitis | Nature Reviews Disease Primers — www.nature.com — https://www.nature.com/articles/s41572-021-00271-4
4. Intervention study to evaluate the importance of information given to ... — academic.oup.com — https://academic.oup.com/bjd/article/184/1/43/6599814
5. A systematic review of allergic and irritant contact dermatitis of the vulva: The most important allergens/irritants and the role of patch testing - Vandeweege - 2023 - Contact Dermatitis - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/cod.14258
6. European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cod.12432
7. Irritant Diaper Dermatitis - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/immunology-and-microbiology/irritant-diaper-dermatitis
8. CLINICAL IRRITANT CONTACT DERMATITIS SYNDROMES - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0889856105703155
9. ACDS 33rd Annual Meeting Abstracts, Thursday,... : Dermatitis - Ovid — journals.lww.com — https://journals.lww.com/01206501-202205000-00017
10. AI-Assisted Automated Two-Stage Patch Test... : Contact Dermatitis — journals.lww.com — https://journals.lww.com/00003184-202610000-00003
11. Factors Associated With Irritant Reactions on Epicutaneous Patch ... — journals.lww.com — https://journals.lww.com/00000936-202667010-00006
12. Analysis of Patch Testing for Allergic Contact Dermatitis in ... - Ovid — journals.lww.com — https://journals.lww.com/ijd/fulltext/9900/analysis_of_patch_testing_for_allergic_contact.268.aspx
13. Wet dressing therapy in conjunction with topical corticosteroids is ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0190962211008243
14. Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S019096221401264X
15. Posters (P) - 2018 - Contact Dermatitis — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/cod.13111
16. ESCD Abstracts: Posters - 2016 - Contact Dermatitis — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/cod.12637
17. Guideline contact dermatitis — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4484750
18. Contact Dermatitis: A Practice Parameter-Update 2015 — www.jaci-inpractice.org — https://www.jaci-inpractice.org/article/S2213-2198(15)00116-6/pdf
19. Irritant Contact Dermatitis — a Review — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8989112
20. Recognizing and Managing Allergic Contact Dermatitis — www.jaci-inpractice.org — https://www.jaci-inpractice.org/article/S2213-2198(24)00525-7/abstract
21. Allergic contact dermatitis in patients with atopic dermatitis — www.jaci-inpractice.org — https://www.jaci-inpractice.org/article/S2213-2198(19)30330-7/fulltext
22. The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5948135
23. Contact dermatitis. - Abstract - Europe PMC — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/9048524
24. Learning module: Contact dermatitis — www.aad.org — https://www.aad.org/member/education/residents/bdc/contact-dermatitis

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.